Viewing Study NCT07194850


Ignite Creation Date: 2025-12-24 @ 5:00 PM
Ignite Modification Date: 2026-01-05 @ 1:05 AM
Study NCT ID: NCT07194850
Status: RECRUITING
Last Update Posted: 2025-11-25
First Post: 2025-09-19
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP)
Sponsor: argenx
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module